Gilead Announces First Global Regulatory Approval of Sunlenca® (Lenacapavir), the Only ...

Retrieved on: 2022-08-22 08:00:29

Tags for this article:

Prevention of HIV/AIDS

HIV/AIDS

Medicine

Hepatotoxins

Health

Management of HIV/AIDS

Treatment as prevention

Pre-exposure prophylaxis

Click the tags to see associated articles and topics

Gilead Announces First Global Regulatory Approval of Sunlenca® (Lenacapavir), the Only .... View article details on HISWAI: https://pipelinereview.com/index.php/2022082281455/Small-Molecules/Gilead-Announces-First-Global-Regulatory-Approval-of-Sunlenca-Lenacapavir-the-Only-Twice-Yearly-HIV-Treatment-Option.html

Excerpt

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and ... PipelineReview.com is powered by La Merie Business Intelligence La ...

Article found on: pipelinereview.com

View Original Article